No abstract

The Blue Genet/L computer is a massively parallel supercomputer based on IBM system-on-a-chip technology. It is designed to scale to 65,536 dual-processor nodes, with a peak performance of 360 teraflops. This paper describes the project objectives and provides an overview of the system architecture that resulted. We discuss our application-based approach and rationale for a low-power, highly integrated design. The key architectural features of Blue Gene/L are introduced in this paper: the link chip component and five Blue Gene/L networks, the PowerPCt 440 core and floatingpoint enhancements, the on-chip and off-chip distributed memory system, the node-and system-level design for high reliability, and the comprehensive approach to fault isolation.

, IBM announced the start of a five-year effort to build a massively parallel computer, to be applied to the study of biomolecular phenomena such as protein folding. The project has two main goals: to advance our understanding of the mechanisms behind protein folding via large-scale simulation, and to explore novel ideas in massively parallel machine architecture and software. This project should enable biomolecular simulations that are orders of magnitude larger than current technology permits. Major areas of investigation include: how to most effectively utilize this novel platform to meet our scientific goals, how to make such massively parallel machines more usable, and how to achieve performance targets, with reasonable cost, through novel machine architectures. This paper provides an overview of the Blue Gene project at IBM Research. It includes some of the plans that have been made, the intended goals, and the anticipated challenges regarding the scientific work, the software application, and the hardware design.

No abstract

No abstract